CD68+ cell count was no significant difference in different patient age, tumor size, TNM clinical stage and lymph node status groups (all the probability is beyond 0.05). 2.

• 乳腺癌组织中，CD68+细胞数与患者年龄、肿瘤大小、腋窝淋巴结转移以及TNM临床分期无关（P均大于0.；05）。